戻る Agenda
Session2
Session Chair(s)
Shohko Sekine
Reviewer, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
S2-1
Kazuhiko Ishida, MSC, RPH
Astellas Pharma Inc., Japan
Director, Pharmacovigilance
S2-2
Kanae Ogiwara
Pfizer Japan Inc., Japan
Promotion Material Review, Medical